GlycoPath is Diagnostic Equipment in United States that focus on glycan profiling technology business. Founded in 2019. They cover business area such as developer, advanced bioanalytical assay, liver fibrosis, diagnostic glycoprotein, blood, multiplexed antibody slide array, direct analysis, each glycoprotein, MALDI-TOF mass spectrometry, clinician, clinical glycomic assay, detection, hepatic fibrosis.
2019
( 5 years old in 2024 )
Glycan Profiling Technology
-
4058 Blackmoor Street
Mount Pleasant, SC 29466-7160
United States
Private
developeradvanced bioanalytical assayliver fibrosisdiagnostic glycoproteinbloodmultiplexed antibody slide arraydirect analysiseach glycoproteinMALDI-TOF mass spectrometryclinicianclinical glycomic assaydetectionhepatic fibrosis
* We use standard office opening hours in near GlycoPath's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
GlycoPath is Diagnostic Equipment business from United States that founded in 2019 (5 years old in 2024), GlycoPath business is focusing on Glycan Profiling Technology.
GlycoPath headquarter office and corporate office address is located in 4058 Blackmoor Street Mount Pleasant, SC 29466-7160 United States.
GlycoPath was founded in United States.
In 2024, GlycoPath is currently focus on glycan profiling technology sector.
Above is snippet of Google Trends for "glycan profiling technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with GlycoPath, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
